Comments
Loading...
Enliven Therapeutics Stock Short Interest Report | NASDAQ:ELVN | Benzinga
Short interest in Enliven Therapeutics Inc (NASDAQ:ELVN) decreased during the last reporting period, falling from 7.38M to 7.34M. This put 35.17% of the company's publicly available shares short.
Short interest in Enliven Therapeutics Corp (XNAS:ELVN) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 243.50K shares traded per day, it would take 30.12 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
7.34M
Short Interest %
35.2%
Days to Cover
30.12
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. Com | 03/14/2025 | 03/25/2025 | 35.17% | 20,859,053 | 7,335,188 | 243,504 | 30.12 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 02/28/2025 | 03/11/2025 | 35.61% | 20,713,794 | 7,375,213 | 143,703 | 51.32 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 02/14/2025 | 02/26/2025 | 35.93% | 20,713,794 | 7,442,501 | 216,755 | 34.34 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 01/31/2025 | 02/11/2025 | 34.33% | 20,713,794 | 7,110,223 | 264,877 | 26.84 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 01/15/2025 | 01/27/2025 | 34.26% | 20,713,794 | 7,096,259 | 265,202 | 26.76 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 12/31/2024 | 01/10/2025 | 33.46% | 20,713,794 | 6,930,336 | 222,119 | 31.2 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 12/13/2024 | 12/24/2024 | 33.18% | 20,713,794 | 6,873,517 | 154,258 | 44.56 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 11/29/2024 | 12/10/2024 | 33.35% | 20,713,794 | 6,908,627 | 191,333 | 36.11 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 11/15/2024 | 11/26/2024 | 34.11% | 20,713,794 | 7,065,704 | 288,595 | 24.48 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 10/31/2024 | 11/11/2024 | 36.17% | 19,091,835 | 6,906,424 | 193,875 | 35.62 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 10/15/2024 | 10/24/2024 | 34.11% | 19,091,835 | 6,512,482 | 395,295 | 16.47 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 09/30/2024 | 10/09/2024 | 31.97% | 19,091,835 | 6,104,584 | 290,907 | 20.98 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 09/13/2024 | 09/24/2024 | 28.98% | 19,091,835 | 5,532,400 | 153,836 | 35.96 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 08/30/2024 | 09/11/2024 | 28.00% | 19,091,835 | 5,346,353 | 114,829 | 46.56 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 08/15/2024 | 08/26/2024 | 27.87% | 19,091,835 | 5,320,217 | 165,261 | 32.19 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 07/31/2024 | 08/09/2024 | 28.07% | 18,891,326 | 5,303,666 | 262,785 | 20.18 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 07/15/2024 | 07/24/2024 | 27.77% | 18,891,326 | 5,245,830 | 263,175 | 19.93 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 06/28/2024 | 07/10/2024 | 31.02% | 18,891,326 | 5,860,518 | 583,331 | 10.05 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 06/14/2024 | 06/26/2024 | 29.38% | 18,891,326 | 5,550,788 | 173,823 | 31.93 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 05/31/2024 | 06/11/2024 | 28.78% | 18,891,326 | 5,436,600 | 333,746 | 16.29 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 05/15/2024 | 05/24/2024 | 28.08% | 18,891,326 | 5,304,615 | 329,551 | 16.1 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 04/30/2024 | 05/09/2024 | 25.05% | 18,891,326 | 4,731,532 | 359,833 | 13.15 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 04/15/2024 | 04/24/2024 | 24.60% | 18,860,076 | 4,640,194 | 630,134 | 7.36 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 03/28/2024 | 04/09/2024 | 14.76% | 28,671,249 | 4,232,833 | 200,783 | 21.08 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 03/15/2024 | 03/26/2024 | 18.57% | 23,314,105 | 4,329,707 | 123,255 | 35.13 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 02/29/2024 | 03/11/2024 | 18.59% | 23,314,105 | 4,334,002 | 67,716 | 64 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 02/15/2024 | 02/27/2024 | 21.16% | 23,178,446 | 4,905,679 | 166,882 | 29.4 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 01/31/2024 | 02/09/2024 | 22.26% | 23,178,446 | 5,159,762 | 126,338 | 40.84 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 01/12/2024 | 01/24/2024 | 22.23% | 23,178,446 | 5,153,619 | 137,429 | 37.5 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 12/29/2023 | 01/10/2024 | 23.77% | 23,178,446 | 5,508,477 | 211,086 | 26.1 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 12/15/2023 | 12/27/2023 | 22.91% | 23,178,446 | 5,309,114 | 224,825 | 23.61 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 11/30/2023 | 12/11/2023 | 22.61% | 23,178,446 | 5,239,968 | 89,460 | 58.57 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 11/15/2023 | 11/27/2023 | 22.51% | 23,178,446 | 5,218,474 | 63,695 | 81.93 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 10/31/2023 | 11/09/2023 | 22.36% | 23,117,584 | 5,170,183 | 63,791 | 81.05 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 10/13/2023 | 10/24/2023 | 22.08% | 23,117,584 | 5,104,494 | 62,288 | 81.95 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 09/29/2023 | 10/10/2023 | 22.19% | 23,117,584 | 5,130,837 | 166,852 | 30.75 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 09/15/2023 | 09/26/2023 | 22.35% | 23,117,584 | 5,166,408 | 92,841 | 55.65 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 08/31/2023 | 09/12/2023 | 22.17% | 23,117,584 | 5,124,466 | 126,665 | 40.46 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 08/15/2023 | 08/24/2023 | 22.94% | 23,117,584 | 5,303,387 | 75,390 | 70.35 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 07/31/2023 | 08/09/2023 | 23.21% | 23,081,268 | 5,357,950 | 82,609 | 64.86 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 07/14/2023 | 07/25/2023 | 23.48% | 23,081,268 | 5,420,294 | 155,721 | 34.81 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 06/30/2023 | 07/12/2023 | 23.17% | 23,081,268 | 5,347,141 | 625,543 | 8.55 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 06/15/2023 | 06/27/2023 | 16.57% | 23,081,268 | 3,825,175 | 232,752 | 16.43 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 05/31/2023 | 06/09/2023 | 12.82% | 23,081,268 | 2,959,095 | 164,170 | 18.02 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 05/15/2023 | 05/24/2023 | 11.76% | 23,081,268 | 2,714,299 | 77,736 | 34.92 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 04/28/2023 | 05/09/2023 | 9.02% | 23,081,268 | 2,082,785 | 121,260 | 17.18 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 04/14/2023 | 04/25/2023 | 6.63% | 23,081,268 | 1,530,139 | 144,513 | 10.59 | Get Alert |
| ELVN | Enliven Therapeutics, Inc. Com | 03/31/2023 | 04/12/2023 | 3.80% | 23,072,750 | 876,933 | 145,913 | 6.01 | Get Alert |
Looking for the most shorted stocks?